SDX 0.00% 7.0¢ sienna cancer diagnostics limited

Ann: Sienna & VivaZome Evaluate EXO-NET for Exosome Therapeutics, page-17

  1. 3,040 Posts.
    lightbulb Created with Sketch. 403
    GLTA I sincerely hope this investment takes off. No bad blood but have given my 2c on concerns with illiquid companies as have experienced first hand myself.
 
watchlist Created with Sketch. Add SDX (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.